Search

Partial discharge (PD) is the primary factor causing insulation degradation in transformers. However, the collected signals of partial discharge are often contaminated with significant noise. This makes it difficult to extract the PD signal and hinders subsequent signal analysis and processing. This paper proposes a denoising method for transformer partial discharge based on the Whale VMD algorithm combined with adaptive filtering and wavelet thresholding (WVNW). First, the WOA is used to optimize the important parameters of the VMD. The selected mode components from the VMD decomposition are then subjected to preliminary denoising based on the kurtosis criterion. The reconstructed signal is further denoised using the Adaptive Filter (NLMS) algorithm to remove narrowband interference noise. Finally, the residual white noise is eliminated using the Wavelet Thresholding algorithm. In simulation experiments and practical measurements, the proposed method is compared quantitatively with previous methods, VMD-WT, and EMD-WT, based on metrics such as SNR, RMSE, NCC, and NRR. The results indicate that the WVNW method effectively suppresses noise interference and restores the original PD signal waveform with high waveform similarity while preserving a significant amount of local discharge signal features. [ABSTRACT FROM AUTHOR]

Nitric oxide (NO) is an important gas messenger molecule with a wide range of biological functions. High concentration of NO exerts promising antitumor effects and is regarded as one of the hot spots in cancer research, that have limitations in their direct application due to its gaseous state, short half-life (seconds) and high reactivity. Lysyl oxidase (LOX) is a copper-dependent amine oxidase that is responsible for the covalent bonding between collagen and elastin and promotes tumor cell invasion and metastasis. The overexpression of LOX in triple-negative breast cancer (TNBC) makes it an attractive target for TNBC therapy. Herein, novel NO donor prodrug molecules were designed and synthesized based on the naturally derived piperlongumine (PL) skeleton, which can be selectively activated by LOX to release high concentrations of NO and PL derivatives, both of them play a synergistic role in TNBC therapy. Among them, the compound TM-1 selectively released NO in highly invasive TNBC cells (MDA-MB-231), and TM-1 was also confirmed as a potential TNBC cell line inhibitor with an inhibitory concentration of 2.274 μM. Molecular docking results showed that TM-1 had a strong and selective binding affinity with LOX protein., Competing Interests: Declaration of competing interest The authors declare no conflict of interest., (Copyright © 2024 Elsevier B.V. All rights reserved.)